A multinational company founded on the history of an innovative Italian family-owned enterprise
1906, Vicenza: the Zambon story begins
The first step on the path that would lead to the "Zambon world” took place in Italy at the start of the 20th century. On November 11, 1906, Gaetano Zambon, with a degree in pharmacy and varied experience in the chemical products business, partnered with Silvio Farina to establish the "Zambon Medicinal Warehouse” in Vicenza.
The start of industrial production
In the 1920s, the company started to produce galenic formulations, and in 1933 the manufacturing cycle was completed with the synthesis of raw materials. After the plant was destroyed by bombing in World War II, in 1946 a new, larger, more functional plant was opened, accommodating 500 production employees and 50 researchers. That was the starting point of industrial production of pharmaceuticals, thanks to significant acceleration in research.
The post-war renaissance
In the post-war years, the baton was passed to Alberto Zambon, who moved the company's headquarters from Vicenza to Bresso (Milan), intensified research and permanently abandoned galenic formulation in order to focus on industrial production. Alberto understood the importance of “proprietary” products, the fruit of internal research, and the need to find new markets. In the 1950s, he started to expand the group in Europe and overseas, with the first industrial facility in Brazil in 1956.
Expansion in Europe and around the World
From the 1960s, with the opening of a subsidiary in Barcelona, Zambon adopted a bold strategy of internationalization, a process that is ongoing to this day. This expansion saw the group’s presence grow through the establishment of facilities not only in the major European countries, but also in South America (Brazil and Colombia) and the Far East (Indonesia, China and India).
More than one hundred years after its inception, the Zambon Group is a multinational institution that is present in 87 countries and has nearly three thousand employees throughout the world. In the new millennium, several innovative projects have come to life in the Zambon world, such as the Zcube Research Venture, the Fondazione Zoé, the Benvivere philosophy and the OpenZone scientific campus.
Zambon today: a new growth phase
In recent years, Zambon has entered a new growth phase, a renewed path that confirms the international vocation of the company and its desire to provide innovative solutions to improve patients’ quality of life, with a specialization in treating severe diseases such as Parkinson's, Cystic Fibrosis, BOS and NCFB.
Severe Respiratory Diseases
With its extensive experience in respiratory health, in future years Zambon will continue to invest in this area, developing new treatment devices and solutions to meet the needs of patients with severe respiratory diseases, thanks also to a dynamic network and partnership with universities and research centers.
Central Nervous System
Aside from its established areas of operation, Zambon intends to renew its commitment in the area of the Central Nervous System by developing new treatment solutions to improve the lives of patients suffering from Parkinson's Disease and ALS.